GSK plc (GSK) stock chart and technical analysis
Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-11-05, the close was $50.41: 2.3% above the 50-day average and 2.7% below the 200-day average, which is rising. RSI (14) is 55, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 37% of the way up its 52-week range of $44.61 to $60.09, on 0.5x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $49.27 | Price 2.3% above |
| 200-day average | $51.79 | Price 2.7% below, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 55 | Neutral range |
| MACD (12, 26, 9) | +0.29 vs +0.20 | Bullish cross in the last 10 days |
| 52-week range | $44.61 to $60.09 | 37% of the way up the range |
| Volume vs 20-day average | 0.5x | Light |
What followed this setup for GSK
- When it closed below its 200-day average (2,446 days), it was higher 63 trading days later 61% of the time, median +2.4%.
- When it closed above its 50-day average (3,810 days), it was higher 63 trading days later 55% of the time, median +0.9%.
- When it had MACD above its signal line (3,337 days), it was higher 63 trading days later 58% of the time, median +1.5%.
- All days since 1999 (6,732 days): higher 63 trading days later 57% of the time, median +1.4%.
Base rates use GSK's own daily history since 1999; they describe the past, not a forecast.
Questions about GSK's chart
What is GSK's RSI today?
As of 2026-11-05, GSK's 14-day RSI is 55, which is in the neutral range between 30 and 70.
Is GSK above its 200-day moving average?
No. GSK closed at $50.41 on 2026-11-05, 2.7% below its 200-day average of $51.79, which is rising. When it closed below its 200-day average (2,446 days), it was higher 63 trading days later 61% of the time, median +2.4%.
Is GSK above its 50-day moving average?
Yes. GSK closed at $50.41 on 2026-11-05, 2.3% above its 50-day average of $49.27. When it closed above its 50-day average (3,810 days), it was higher 63 trading days later 55% of the time, median +0.9%.
Has GSK had a MACD crossover?
Yes, a bullish cross within the last 10 trading days. As of 2026-11-05 the MACD line is +0.29 against a signal line of +0.20, so MACD is bullish.
Is GSK near its 52-week high?
No. At $50.41 it sits 37% of the way up its 52-week range of $44.61 to $60.09, 16.1% below the high.
What is GSK's technical rating today?
Neutral: 2 of 5 indicators are bullish and 2 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
GSK analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.